Polianta Ltd’s Bristol-Myers Squibb BMY Stock Holding History

Polianta Ltd’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,600	Closed	-$1.26M	–	67
2019 Q4	$1.26M	Sell	19,600 -5,700	-23%	-$326K	0.77%	11
2019 Q3	$1.28M	Buy	+25,300	New	+$1.19M	0.81%	10
2018 Q4	–	Sell	-20,700	Closed	-$1.28M	–	62
2018 Q3	$1.28M	Buy	+20,700	New	+$1.23M	0.65%	27

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Polianta Ltd's BMY Position: Q1 2020 in Review

Polianta Ltd sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 19,600 shares — an estimated $1.26M sold.

Polianta Ltd first reported a position in BMY in Q3 2018 and held it in 3 quarters. The position peaked at $1.28M in Q3 2018. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

Polianta Ltd reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
Polianta Ltd sold 19,600 Bristol-Myers Squibb shares in Q1 2020, an estimated $1.26M.
Polianta Ltd first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 3 quarters.
Polianta Ltd's Bristol-Myers Squibb position peaked at $1.28M in Q3 2018.
2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Polianta Ltd's 13F filing for Q1 2020, filed 7 Apr 2020.